Page 246 - The Memory Program How to Prevent Memory Loss and Enhance Memory Power

Page 235

Tierney, M. C., Szalai. J. P., Snow, W. G., Fisher, R. H., Tsuda, T., Chi, H., McLachlan, D. R., St. George -Hyslop, P. H.
A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory
impairment. Neurology 46:149 –154, 1996.

Tierney, M. C., Szalai, J. P., Snow, W. G., Fisher, R. H., Nores, A., Nadon, G., Dunn, E., et al. Prediction of probable
Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 46:661–665, 1996.

Tracy, J. I., Bates, M. E. The selective effects of alcohol on automatic and effortful memory processes. Neuropsychology
13:282–290, 1999.

Trojanowski, J. Q., Growdon, J. H. A new consensus report on biomarkers for the carly antemortem diagnosis of
Alzheimer disease: current status, relevance to drug discovery, and recommendations for future research (editorial).
Journal of Neuropathology and Experimental Neurology 57:643 –644, 1998.

Tune, L., Carr, S., Hoag, E., Cooper, T. Anticholinergic effects of drugs commonly prescribed for the elderly: potential
means for assessing risk of delirium. American Journal of Psychiatry 149:1393–1394, 1992.

Van Ginj J., Low doses of aspirin in stroke prevention. Lancet 353:2172–2173, 1999.

Van Gorp, W. G., Wilkins, J. N., Moore, L. H., Hull, J., Horner, M. D., Plotkin, D. Declarative and procedural memory
functioning in abstinent cocaine abusers. Archives of General Psychiatry 56:85–89, 1999.

Van Ryn, J., Pairet, M. Clinical experience with cyclooxygenase-2 inhibitors. Inflammation Research 48:247–254, 1999.

Verhaeghen, P., Marcoen,A., Goossens, L. Facts and fiction about memory aging: a quantitative integration of research
findings. Journal of Gerontology 48:157 –171, 1993.

Vernon, M. W., Sorkin, E. M. Piracetam. An overview of its pharmacological properties and a review of its therapeutic
use in senile cognitive disorders. Drugs and Aging 1:17–35, 1991.

Warburton, D. M. Effects of caffeine on cognition and mood without caffeine abstinence. Psychopharmacology (Berlin)
119:66–70, 1995.

Watkins, P. B., Zimmerman, H.J., Knapp, M. J., Gracon, S. I., Lewis, K. W. Hepatotoxic effects of tacrine administration
in patients with Alzheimer's disease. Journal of the American Medical Association 271:992–998, 1994.

West, R. L., Crook, T. H., Barron, K. L. Everyday memory performance across the life span: effects of age and
noncognitive individual diffrences. Psychology and Aging 7:72–82, 1992.

Wolf, O. T., Neumann, O., Hellhammer, D. H., Geiben, A. C., Strassburger, C. J., Dressendorfer, R. A., et al. Effects of a
two-week physiological DHEA substitution on cognitive performance and well -being in healthy elderly women and
men. Journal of Endocrinological Investigation 82:2363–2367, 1997.

Woodle, E. S., Kulkarni, S. Programmed cell death. Transplantation 66:681–691, 1998.

Yaffe, K., Ettinger, B., Pressman, A., Seeley, D., Whooley, M., Schaefer, C., Cummings, S. Neuropsychiatric function
and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biological Psychiatry 43:694–700, 1998.

Yaffe, K., Sawaya, G., Lieberburg, I., Grady, D. Estrogen therapy in postmenopausal women: effects on cognitive
function and dementia. Journal of the American Medical Association 279:688–695, 1998.

Young, E. A. DHEA: Mood, memory, and aging. Biological Psychiatry 45:1531–1532, 1999.

Zola-Morgan, S. M., Squire, L. R. The primate hippocampal formation: evidence for a time-limited role in memory
storage. Science 250:288–290, 1990.